Quest Diagnostics Inc (DGX)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Miller Officer	$54.57	12,717	$693,966.69	4,473	2009-08-20	Filing
Miller Officer	$54.60	3,400	$185,640.00	58,859	2009-08-20	Filing
Miller Officer	$54.50	15,000	$817,500.00	58,859	2009-08-20	Filing
Miller Officer	$54.80	5,514	$302,167.20	58,859	2009-08-17	Filing
Mohapatra Officer, Director	$53.51	11,236	$601,203.53	225,202	2009-08-13	Filing
Buehler Director	$54.13	20,000	$1,082,694.00	18,629	2009-08-03	Filing
Prevoznik Officer	$55.12	68,000	$3,748,228.00	44,118	2009-07-29	Filing
Miller Officer	$56.20	14,300	$803,660.00	64,351	2009-07-28	Filing
Miller Officer	$56.20	9,200	$517,040.00	64,351	2009-07-27	Filing
Bongiorno Officer	$56.00	3,000	$168,007.80	10,768	2009-07-27	Filing
Mohapatra Officer, Director	$55.87	26,896	$1,502,679.52	225,202	2009-07-23	Filing
Mohapatra Officer, Director	$55.49	125,104	$6,942,020.96	252,098	2009-07-23	Filing
Miller Officer	$56.00	4,274	$239,344.00	64,351	2009-07-23	Filing
Hagemann Officer	$55.60	31,000	$1,723,680.60	85,803	2009-07-23	Filing
Hagemann Officer	$55.61	81,218	$4,516,532.98	116,803	2009-07-23	Filing
Glaxosmithkline Large Shareholder, Director	$44.33	4,511,657	$199,999,950.15	30,755,151	2009-03-19	Filing
Glaxosmithkline Large Shareholder, Director	$45.24	7,205	$325,960.68	35,266,808	2009-03-19	Filing
Glaxosmithkline Large Shareholder, Director	$44.36	230,295	$10,216,001.35	35,274,013	2009-03-19	Filing
Glaxosmithkline Large Shareholder, Director	$46.40	21,101	$979,170.80	35,504,308	2009-03-18	Filing
Glaxosmithkline Large Shareholder, Director	$45.67	478,899	$21,872,849.81	35,525,409	2009-03-18	Filing